ShareValue.ai

ShareValue scores for EMV.AU: Valuation 38, Quality 52, Growth 55, Health 47.

EMV.AU
ASX

Emvision Medical Devices Ltd

A$1.51(-0.66%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-5% to 10%
Valuation
38
Overvalued
Price vs Value
Quality
52
Moderate
Business Strength
Growth
55
Moderate
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
56
Neutral
Price Trend

Company Details

About

EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia. It offers non-invasive brain scanners, including emu Brain Scanner, a bedside device; and First Responder Brain Scanner, a device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients. The company was incorporated in 2017 and is based in Macquarie Park, Australia.

Score Analysis

AI Investment Thesis

Data as of:Jun 29, 2026
|
Last calculated:Jun 29, 2026